人福医药：咪达唑仑注射液获德国联邦药品和医疗器械管理局上市许可

Core Viewpoint - The company has received approval from the German Federal Institute for Drugs and Medical Devices (BfArM) for the marketing authorization of midazolam injection, which will positively impact its international business expansion [1] Group 1 - The company's subsidiary, Yichang Renfu Pharmaceutical Co., Ltd., is responsible for the midazolam injection that has received the approval [1] - The approval allows the company to sell midazolam injection in Germany, marking a significant step in its international market strategy [1]